非经典IDH突变胶质瘤的特征分析
该回顾性研究分析了166例非经典IDH突变胶质瘤患者,并与155例IDH1 p.R132H突变胶质瘤患者比较。非经典突变组诊断年龄中位数38岁,家族癌症史更常见(22.2% vs 5.1%),幕下和多中心病变更频繁,IDH1非经典突变多为星形细胞瘤,IDH2突变多为少突胶质细胞瘤,但总生存相似。
要点
- 非经典IDH突变胶质瘤诊断年龄中位数38岁,家族癌症史占22.2%。
- 非经典突变幕下病变占5.5%,多中心病变占4.8%,均高于IDH1 p.R132H突变。
- IDH1非经典突变多为星形细胞瘤(65.6%),IDH2突变多为少突胶质细胞瘤(85%)。
核心结论
- 非经典IDH突变胶质瘤具有独特的影像学和组织学特征,且可能与癌症遗传易感性相关。
研究设计与样本
- 回顾性分析166例非经典IDH突变胶质瘤患者,并与155例连续IDH1 p.R132H突变胶质瘤患者比较。
主要发现
- 非经典IDH突变组诊断年龄中位数38岁,IDH1 p.R132H突变组43岁。
- 非经典IDH突变组家族癌症史占22.2%,IDH1 p.R132H突变组占5.1%(P < 0.05)。
- 非经典IDH突变组幕下病变占5.5%,IDH1 p.R132H突变组占0%(P < 0.05)。
- 非经典IDH突变组多中心病变占4.8%,IDH1 p.R132H突变组占0.9%(P < 0.05)。
- IDH1非经典突变组星形细胞瘤占65.6%,IDH1 p.R132H突变组占43%(P < 0.05);IDH2突变组少突胶质细胞瘤占85%,IDH1 p.R132H突变组占48.3%(P < 0.05)。
临床怎么用
- 对非经典IDH突变胶质瘤应关注幕下和多中心病变可能,并详细询问家族癌症史。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Approximately 10% of IDH-mutant gliomas harbour non-canonical IDH mutations (non-p.R132H IDH1 and IDH2 mutations). OBJECTIVE: The aim of this study was to analyse the characteristics of non-canonical IDH-mutant gliomas. MATERIALS AND METHODS: We retrospectively analysed the characteristics of 166 patients with non-canonical IDH mutant gliomas and compared them to those of 155 consecutive patients with IDH1 p.R132H mutant gliomas. RESULTS: The median age at diagnosis was 38 years in patients with non-canonical IDH mutant gliomas and 43 years in glioma patients with IDH1 p.R132H-mutant tumours. Family history of cancer was more frequent among glioma patients harbouring non-canonical IDH mutations than in patients with IDH1 p.R132H mutations (22.2% vs 5.1%; P < 0.05). Tumours were predominantly localised in the frontal lobe regardless of the type of IDH mutation. Compared to IDH1 p.R132H-mutant gliomas, tumours with non-canonical IDH mutations were more frequently found in the infratentorial region (5.5% vs 0%; P < 0.05) and were often multicentric (4.8% vs 0.9%; P < 0.05). Compared to IDH1 P.R132H-mutant gliomas, tumours with non-canonical IDH1 mutations were more frequently astrocytomas (65.6% vs 43%, P < 0.05), while those with IDH2 mutations were more frequently oligodendrogliomas (85% vs 48.3%; P < 0.05). The median overall survival was similar in patients with IDH1 p.R132H-mutant gliomas and patients with non-canonical IDH-mutant gliomas. CONCLUSION: Gliomas with non-canonical IDH mutations have distinct radiological and histological characteristics. The presence of such tumours seems to be associated with genetic predisposition to cancer development.
引用
- Poetsch L, Bronnimann C, Loiseau H, et al. Characteristics of IDH-mutant gliomas with non-canonical IDH mutation. J Neurooncol. 2020. PMID: 33205355. doi:10.1007/s11060-020-03662-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。